Impact of Access to Modern Diabetes Technologies and Insulin on HbA1c Levels in Children with Type 1 Diabetes
Access to advanced diabetes technologies and insulin significantly influences HbA1c levels in children with type 1 diabetes, with disparities affecting health outcomes worldwide. A new study emphasizes the need for global policy efforts to improve technology availability and reimbursement.
Recent research published in JAMA Network Open highlights the significant influence of access to advanced diabetes management technologies and insulin on glycemic control in children with type 1 diabetes (T1D). The study, led by Dr. Alzbeta Santova from Motol University Hospital in Prague, analyzed data from 81 centers across 56 countries, involving over 42,000 children with T1D.
The findings reveal stark disparities in the availability and reimbursement of modern diabetes management tools such as continuous glucose monitors (CGMs), insulin pumps, and traditional glucometers. Centers in countries with full reimbursement policies for these technologies reported average HbA1c levels of 7.62% to 7.75%. In contrast, centers where these technologies and insulin were either unavailable or not reimbursed showed much higher average HbA1c levels ranging from 9.65% to 10.49%, indicating poorer glycemic control.
The study underscores that equitable access to modern diabetes management tools is critical for improving health outcomes globally. The authors emphasize that addressing disparities in technology availability and insurance coverage is essential to closing the gap in diabetes care for children worldwide. They call for increased efforts and innovative solutions to ensure all children with T1D have access to the necessary tools for effective management.
Disclosure of potential conflicts includes ties to the pharmaceutical industry by some authors. The data and conclusions are based on a comprehensive international registry, reinforcing the urgent need for healthcare policy reforms to promote equitable access.
This research adds to the growing understanding that technological accessibility is a cornerstone of optimal diabetes management and highlights the ongoing challenges and opportunities to improve health equity across nations.
Source: MedicalXpress
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative AI Tool Uncovers Hidden Disease Indicators Through Cellular Genetic Analysis
McGill University researchers have created an AI-powered tool that detects subtle disease markers within cells by analyzing gene splicing at the exon level, promising earlier diagnosis and personalized treatment options.
Germany Embraces Digital Health: Insurers Cover 56 Health Apps on Prescription
Germany is leading the way in digital healthcare, with health insurers now covering 56 prescription apps that support mental health, lifestyle, and wellness, transforming patient care and reducing costs.
Enhancing Cancer Outcomes Through Improved Lynch Syndrome Testing: A Cost-Effectiveness Analysis
A comprehensive analysis demonstrates that universal Lynch syndrome testing for colorectal cancer patients significantly enhances early detection and is cost-effective, leading to improved cancer prevention and reduced healthcare costs.
Respiratory Infections Can Reactivate Dormant Breast Cancer Cells in the Lungs
New studies reveal that respiratory viruses like COVID-19 and influenza can awaken dormant breast cancer cells in the lungs, increasing metastasis risk in cancer survivors. Insights from mouse models and population data suggest immune responses, particularly IL-6, play a key role, highlighting the importance of preventive measures and targeted therapies.